At NINGBO INNO PHARMCHEM CO.,LTD., we are deeply involved in providing the chemical building blocks that form the foundation of modern medicine. A prime example of such a critical compound is 2-Chloro-4-amino-6,7-dimethoxyquinazoline, identified by its CAS number 23680-84-4. This pharmaceutical intermediate is indispensable in the synthesis of several key therapeutic agents, most notably alpha-blocker drugs used to manage prevalent health conditions like hypertension and benign prostatic hyperplasia (BPH).

The molecular structure of 2-chloro-4-amino-6,7-dimethoxyquinazoline, with its formula C10H10ClN3O2 and molecular weight of 239.66, is specifically designed to facilitate efficient chemical transformations. Its primary application is in the manufacturing of medications such as prazosin, doxazosin, terazosin, and alfuzosin. These drugs work by selectively blocking alpha-1 adrenergic receptors, leading to vasodilation and relief from symptoms that impact millions globally. The reliability of this intermediate is a direct factor in the consistent availability of these important therapies. The ongoing need for alpha-blocker synthesis ensures a steady market for this chemical.

The pharmaceutical industry demands intermediates of the highest purity, and 2-chloro-4-amino-6,7-dimethoxyquinazoline is no exception, typically supplied at 99.5% purity. This level of quality is vital, as it directly impacts the safety profile and therapeutic effectiveness of the final API. Manufacturers who buy this intermediate depend on its consistent quality to maintain robust production processes and meet stringent regulatory requirements. NINGBO INNO PHARMCHEM CO.,LTD. is committed to delivering this essential purity, ensuring our clients can trust our products for their critical manufacturing needs.

Furthermore, this compound is not only important for established drug production but also for the future of pharmaceutical innovation. The quinazoline moiety is a privileged scaffold in medicinal chemistry, meaning it is frequently found in biologically active molecules. Researchers utilize 2-chloro-4-amino-6,7-dimethoxyquinazoline as a versatile starting material for developing new drug candidates or exploring modifications to existing therapies. The ability to easily source and work with this intermediate accelerates the pace of drug discovery, potentially leading to novel treatments for a wider range of diseases. The ongoing synthesis of alpha-blockers provides a stable market, while research fuels future demand.

In essence, 2-chloro-4-amino-6,7-dimethoxyquinazoline (CAS 23680-84-4) serves as a critical link in the pharmaceutical manufacturing chain. Its role in producing essential alpha-blocker drugs and its potential for future innovation make it a compound of significant value. NINGBO INNO PHARMCHEM CO.,LTD. takes pride in supplying this vital intermediate, supporting the pharmaceutical industry's continuous efforts to improve global health.